Glutamate-induced nuclear translocation of PYK2 in hippocampal neurons, interaction with MBD2, and role in cell death in a model of epilepsy

Giralt A
Paris University
April 22, 2026
Cell Death Dis
https://pubmed.ncbi.nlm.nih.gov/42020370/

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/42020370/

Research summary

The study investigates how PYK2 nuclear translocation regulates neuronal responses to glutamate and contributes to neurotoxicity during epilepsy. PYK2 interacts with MBD2 and influences chromatin modifications and transcriptional responses in hippocampal neurons.

Key outcome of the study

PYK2 promoted glutamate-induced nuclear localization of MBD2 and influenced chromatin modifications and neuronal gene expression. PYK2 deficiency reduced glutamate-induced neuronal death and decreased aberrant synaptic sprouting and CA3 neuronal death following pilocarpine-induced status epilepticus.

Model

Ptk2b^flox/flox conditional Knockout mouse — genOway-developed, generated by flanking exons 15b–18 with LoxP sites. For this study, the floxed line was crossed with a ubiquitous Cre deleter to generate Ptk2b^-/- mice lacking PYK2 in all cell types. The deletion disrupts the protein kinase domain and prevents PYK2 expression.

TARGET:
Ptk2b
Synonyms:
Pyk2, FAK2, CAKB, CADTK, RAFTK

Keywords

Epilepsy, status epilepticus, neurotoxicity, neuronal cell death, hippocampus, glutamate signaling, synaptic plasticity, chromatin regulation

Technical specifications

Ptk2b conditional Knockout, floxed exons 15b–18, LoxP sites, homologous recombination, Cre-mediated deletion, pilocarpine-induced status epilepticus, hippocampal neuron culture

Related products

Catalogue product

No items found.

Customized product

Tissue-specific KO mouse

Use tissue- or cell-specific conditional Knockout mouse models to bypass embryonic lethality, compensatory mechanisms, complex phenotypes, etc.

Catalogue product

No items found.
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe